Grace Therapeutics, Inc. Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Grace Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2023.
  • Grace Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $1K, a 85.7% decline year-over-year.
  • Grace Therapeutics, Inc. annual Depreciation for 2023 was $11K, a 91.1% decline from 2022.
  • Grace Therapeutics, Inc. annual Depreciation for 2022 was $124K.
  • Grace Therapeutics, Inc. annual Depreciation for 2021 was $0.000, a 100% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11K -$113K -91.1% Apr 1, 2023 Mar 31, 2024 10-K 2024-06-21
2022 $124K +$124K Apr 1, 2022 Mar 31, 2023 10-K 2024-06-21
2021 $0 -$143K -100% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-23
2020 $143K -$267K -65.1% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-21
2019 $410K +$26K +6.77% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-22
2018 $384K Apr 1, 2018 Mar 31, 2019 10-K 2020-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.